Monitoring of Therapy in Congenital Adrenal Hyperplasia
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Congenital adrenal hyperplasia is a group of disorders caused by defects in the adrenal steroidogenic pathways. In its most common form, 21-hydroxylase deficiency, patients develop varying degrees of glucocorticoid and mineralocorticoid deficiency as well as androgen excess. Therapy is guided by monitoring clinical parameters as well as adrenal hormone and metabolite concentrations. CONTENT: We review the evidence for clinical and biochemical parameters used in monitoring therapy for congenital adrenal hyperplasia. We discuss the utility of 24-h urine collections for pregnanetriol and 17-ketosteroids as well as serum measurements of 17-hydroxyprogesterone, androstenedione, and testosterone. In addition, we examine the added value of daily hormonal profiles obtained from salivary or blood-spot samples and discuss the limitations of the various assays. SUMMARY: Clinical parameters such as growth velocity and bone age remain the gold standard for monitoring the adequacy of therapy in congenital adrenal hyperplasia. The use of 24-h urine collections for pregnanetriol and 17-ketosteroid may offer an integrated view of adrenal hormone production but target concentrations must be better defined. Random serum hormone measurements are of little value and fluctuate with time of day and timing relative to glucocorticoid administration. Assays of daily hormonal profiles from saliva or blood spots offer a more detailed assessment of therapeutic control, although salivary assays have variable quality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Joint LWPES/ESPE CAH Working Group (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020611 · Cited by 332
Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.
Merke, D. P., Chrousos, G. P., Eisenhofer, G., Weise, M., Keil, M. F., Rogol, A. D., Van Wyk, J. J., & Bornstein, S. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431903 · Cited by 266
Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency
Charmandari, E., Eisenhofer, G., Mehlinger, S. L., Carlson, A., Wesley, R., Keil, M. F., Chrousos, G. P., New, M. I., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8664 · Cited by 70
Green-Golan, L., Yates, C., Drinkard, B., VanRyzin, C., Eisenhofer, G., Weise, M., & Merke, D. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0493 · Cited by 50
Bode, H. H., Rivkees, S. A., Cowley, D. M., Pardy, K., & Johnson, S. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70413-0 · Cited by 47
Evaluation of Adrenomedullary Function in Patients with Congenital Adrenal Hyperplasia
Tutunculer, F., Saka, N., Arkaya, S. C., Abbasoglu, S., & Bas, F. (2009) · Hormone Research in Paediatrics · doi:10.1159/000249160 · Cited by 15
Cited by
Turcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231
Measurement of salivary cortisol in 2012 – laboratory techniques and clinical indications
Inder, W. J., Dimeski, G., & Russell, A. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04508.x · Cited by 195
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Falhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
Monaghan, P. J., Owen, L. J., Trainer, P. J., Brabant, G., Keevil, B. G., & Darby, D. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011014 · Cited by 111
Kulle, A., Krone, N., Holterhus, P. M., Schuler, G., Greaves, R. F., Juul, A., de Rijke, Y. B., Hartmann, M. F., Saba, A., Hiort, O., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0953 · Cited by 111
Clinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
Gilban, D. L. S., Alves Junior, P. A. G., & Beserra, I. C. R. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0107-2 · Cited by 51
“It is observed that the dose of GC required for suppression of ACTH levels is supraphysiological [6], and therefore poses risks of adverse effects related to hypercortisolism.”
BackgroundJha, S., Turcu, A. F., Sinaii, N., Brookner, B., Auchus, R. J., & Merke, D. P. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa192 · Cited by 39
“A serum 17OHP level of 1200 ng/dL is often used as the upper limit of acceptable range [7, 8].”
BackgroundThe Urinary Steroidome of Treated Children With Classic 21-Hydroxylase Deficiency
Kamrath, C., Wettstaedt, L., Boettcher, C., Hartmann, M. F., & Wudy, S. A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.08.006 · Cited by 30
“However, monitoring of treatment is difficult in CAH [3].”
Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia
Kamrath, C., Hartmann, M. F., Pons-Kühnemann, J., & Wudy, S. A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154354 · Cited by 28
Mendes-dos-Santos, C. T., Martins, D. L., Guerra-Júnior, G., Baptista, M. T. M., de-Mello, M. P., de Oliveira, L. C., Morcillo, A. M., & Lemos-Marini, S. H. V. (2018) · Hormone Research in Paediatrics · doi:10.1159/000492082 · Cited by 26
Nowotny, H. F., Auer, M. K., Lottspeich, C., Schmidt, H., Dubinski, I., Bidlingmaier, M., Adaway, J., Hawley, J., Keevil, B., & Reisch, N. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab446 · Cited by 22
Kamrath, C., Wettstaedt, L., Hartmann, M. F., & Wudy, S. A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00438 · Cited by 18
de Groot, M. J. M., Pijnenburg-Kleizen, K. J., Thomas, C. M. G., Sweep, F. C. G. J., Stikkelbroeck, N. M. M. L., Otten, B. J., & Claahsen-van der Grinten, H. L. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0375 · Cited by 18
Therapy monitoring in congenital adrenal hyperplasia by dried blood samples
Wieacker, I., Peter, M., Borucki, K., Empting, S., Roehl, F.-W., & Mohnike, K. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0303 · Cited by 14
Metadata
- Authors
- Dauber, A., Kellogg, M., & Majzoub, J. A.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-08-01
- Volume
- 56
- Issue
- 8
- Pages
- 1245-1251
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2126682188
- Cited by
- 72
- References
- 6
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.